Syphilis laboratory guidelines: performance characteristics of nontreponemal antibody tests
S Tuddenham, SS Katz… - Clinical Infectious …, 2020 - academic.oup.com
We reviewed the relevant syphilis diagnostic literature to address the following question:
what are the performance characteristics, stratified by the stage of syphilis, for …
what are the performance characteristics, stratified by the stage of syphilis, for …
Neurosyphilis
Neurosyphilis is caused by the bacterium Treponema pallidum subspecies pallidum (T.
pallidum). The organism gains entry into the central nervous system (CNS) early (primary …
pallidum). The organism gains entry into the central nervous system (CNS) early (primary …
[HTML][HTML] CDC laboratory recommendations for syphilis testing, United States, 2024
JR Papp - MMWR. Recommendations and Reports, 2024 - cdc.gov
This report provides new CDC recommendations for tests that can support a diagnosis of
syphilis, including serologic testing and methods for the identification of the causative agent …
syphilis, including serologic testing and methods for the identification of the causative agent …
Ocular syphilis
JM Furtado, M Simões, D Vasconcelos-Santos… - Survey of …, 2022 - Elsevier
Multiple studies around the world suggest that syphilis is re-emerging. Ocular syphilis–with a
wide range of presentations, most of which are subtypes of uveitis–has become an …
wide range of presentations, most of which are subtypes of uveitis–has become an …
Clinical manifestations and ophthalmic outcomes of ocular syphilis at a time of re-emergence of the systemic infection
JM Furtado, TE Arantes, H Nascimento… - Scientific reports, 2018 - nature.com
Recent reports from different world regions suggest ocular syphilis is re-emerging, in parallel
with an increasing incidence of the systemic infection globally. We conducted a large …
with an increasing incidence of the systemic infection globally. We conducted a large …
Current ophthalmology practice patterns for syphilitic uveitis
GF Oliver, RM Stathis, JM Furtado… - British Journal of …, 2019 - bjo.bmj.com
Background Syphilitic uveitis is re-emerging alongside the systemic infection. In July 2017,
an international group of uveitis-specialised ophthalmologists formed the International …
an international group of uveitis-specialised ophthalmologists formed the International …
Doxycycline in the management of sexually transmitted infections
H Peyriere, A Makinson, H Marchandin… - Journal of …, 2018 - academic.oup.com
Doxycycline is a second-generation tetracycline, available worldwide for half a century. It is
an inexpensive broad-spectrum antimicrobial agent largely used in the management of …
an inexpensive broad-spectrum antimicrobial agent largely used in the management of …
The importance of proper and prompt treatment of ocular syphilis: a lesson from permanent vision loss in 52 eyes
X Gu, Y Gao, Y Yan, M Marks, L Zhu… - Journal of the …, 2020 - Wiley Online Library
Background Ocular involvement can occur at any stage of syphilis. Prompt diagnosis and
proper treatment of ocular syphilis are vital to avoid long‐term consequences. Objectives To …
proper treatment of ocular syphilis are vital to avoid long‐term consequences. Objectives To …
[HTML][HTML] Increase in ocular syphilis cases at ophthalmologic reference center, France, 2012–2015
AC Pratas, P Goldschmidt, D Lebeaux… - Emerging infectious …, 2018 - ncbi.nlm.nih.gov
We describe the frequency, demographic and clinical features, and visual outcomes of
ocular syphilis infections observed during 2012–2015 at a tertiary reference center in Paris …
ocular syphilis infections observed during 2012–2015 at a tertiary reference center in Paris …
Association between immune checkpoint inhibitor medication and uveitis: a population-based cohort study utilizing TriNetX database
Objective To explore the associations between the use of immune checkpoint inhibitors
(ICIs) and the risk of developing uveitis among cancer patients. Methods Cancer patients …
(ICIs) and the risk of developing uveitis among cancer patients. Methods Cancer patients …